Healthcare in Australia: Gene Patenting and the Dr. Death Issue
No single issue has dominated health practitioners’ ethical debates in 2014 in Australia, but a controversial decision on gene patenting and the media focus on “Dr. Death,” euthanasia campaigner Dr. Philip Nitschke, have given new life to these two familiar (and global) debates. Currently a dying wi...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Cambridge Univ. Press
2016
|
In: |
Cambridge quarterly of healthcare ethics
Year: 2016, Volume: 25, Issue: 3, Pages: 414-420 |
Further subjects: | B
Philip Nitschke
B gene patenting B Dying with dignity B Australian Green Party B Euthanasia |
Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
Summary: | No single issue has dominated health practitioners’ ethical debates in 2014 in Australia, but a controversial decision on gene patenting and the media focus on “Dr. Death,” euthanasia campaigner Dr. Philip Nitschke, have given new life to these two familiar (and global) debates. Currently a dying with dignity bill, drafted by the Australian Green Party, is under examination. The Senate inquiry into the bill received more than 663 submissions, with 57% opposed and 43% in support of the bill, which has now been referred to a Senate committee. Will this be another of Australia’s failed attempts to legalize euthanasia? The trial of Dr. Nitschke begins on November 10, 2014. |
---|---|
ISSN: | 1469-2147 |
Contains: | Enthalten in: Cambridge quarterly of healthcare ethics
|
Persistent identifiers: | DOI: 10.1017/S0963180116000062 |